Northwest Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$570K Buy
9,631
+13
+0.1% +$726 0.42% 58
2024
Q3
$498K Buy
9,618
+4
+0% +$188 0.38% 65
2024
Q2
$399K Sell
9,614
-622
-6% -$27.8K 0.33% 68
2024
Q1
$450K Buy
10,236
+112
+1% +$5.71K 0.41% 65
2023
Q4
$519K Buy
+10,124
New +$531K 0.47% 65
2023
Q2
$649K Buy
+10,144
New +$680K 0.62% 52

Other funds holding BMY

Northwest Bank & Trust's BMY Position: Q4 2024 in Review

Northwest Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 0.14% in Q4 2024, buying an estimated $726 and bringing the position to 9,631 shares worth $570K. The position accounts for 0.42% of the portfolio, ranked #58.

Northwest Bank & Trust first reported a position in BMY in Q2 2023 and has held it in 6 quarters since. The position peaked at $649K in Q2 2023. 2,493 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Northwest Bank & Trust held 9,631 shares of Bristol-Myers Squibb worth $570K as of Q4 2024.
  • Northwest Bank & Trust bought 13 Bristol-Myers Squibb shares in Q4 2024, an estimated $726.
  • Bristol-Myers Squibb made up 0.42% of Northwest Bank & Trust's portfolio in Q4 2024, its #58 holding.
  • Northwest Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 6 quarters since.
  • Northwest Bank & Trust's Bristol-Myers Squibb position peaked at $649K in Q2 2023.
  • 2,493 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.